Brenda Martone

Go Back

Oncology Nurse Practitioner

  • Northwestern Medicine
  • location United States

Brenda Martone is a board-certified adult nurse practitioner working in GU oncology at Northwestern Medicine, Chicago, IL. She graduated with her BSN from Concordia College/West Suburban College of Nursing in 1989, received her MSN/CNS degree from Loyola University in 1996 and then completed a post-master’s certificate to become an adult nurse practitioner from Rush University in 2008.  Brenda is an advanced oncology certified nurse practitioner and has been an oncology nurse for over 31 years.  She has been a member of several medical advisory boards, as well as developed programs about metastatic and non-metastatic castration-resistant prostate cancer.  Brenda Martone is a frequent national and regional lecturer and a member of the Advanced Practitioner Society for Hematology and Oncology (APSHO).

Brenda Martone has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Astellas, Bhealth and Pfizer. 

Programmes developed by Brenda Martone

Podcast
Oncology Endocrinology 
Podcast: Treatment Intensification in mCSPC – The Nurse Perspective

Listen as GU oncology nurses share their views in this clinical update podcast

Experts
Brenda Martone, Jennifer Sutton
Endorsed by
ZERO
  • download Downloadable
    Resources
  • clock 19 MIN
  • calendar Jun 2023

Educational programme supported by an Independent Medical Education grant from Bayer
Podcast
Oncology 
Shared decision-making in nmCRPC – Treatment considerations to maintain quality of life

Brenda Martone, Nurse Practitioner is joined by Assoc. Prof.  Alicia Morgans from GU CONNECT to discuss shared decision-making in non-metastatic castration-resistant prostate cancer (nmCRPC) and the treatment considerations to maintain quality of life. 

Experts
Brenda Martone, Assoc. Prof. Alicia Morgans
  • download Downloadable
    Resources
  • clock 24 MIN
  • calendar May 2022

Educational programme supported by an Independent Medical Education grant from AstraZeneca
Oncology 
Treatment sequencing for mCRPC: Providing crucial support to the patient

Brenda Martone provides a summary of how a GU nurse can provide crucial support to patients during treatment sequencing decisions for metastatic castration-resistant prostate cancer (mCRPC).

Experts
Brenda Martone
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Medical Education grant from Bayer